A detailed history of Us Bancorp \De\ transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 16,178 shares of MRSN stock, worth $26,208. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,178
Holding current value
$26,208
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$1.23 - $2.25 $19,898 - $36,400
16,178 New
16,178 $30,000
Q2 2023

Aug 09, 2023

BUY
$3.08 - $9.55 $163 - $506
53 New
53 $0
Q3 2022

Oct 27, 2022

BUY
$4.63 - $8.0 $240 - $416
52 New
52 $0
Q1 2021

Apr 28, 2021

SELL
$15.31 - $26.52 $872 - $1,511
-57 Closed
0 $0
Q4 2020

Feb 04, 2021

BUY
$16.84 - $27.59 $959 - $1,572
57 New
57 $2,000

Others Institutions Holding MRSN

About Mersana Therapeutics, Inc.


  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $157M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.